Jacobio Pharma

formerly Jacobio PharmaceuticalsIPO

加科思药业|以患者受益为导向

Public · Beijing, China · Founded 2015 · $55.0M raised

Headquarters
Beijing
Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$55.0M
Last Round
$55.0M Series CAug 2018
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 4 investors for this company. The full record is or through the API.

About

Jacobio Pharmaceuticals is led by a core management team of serial entrepreneurs with more than 20 years of experience in drug development. In their first venture in 2003, the team developed and commercialized China's first targeted anti-cancer drug, icotinib hydrochloride (Conmana®); with Jacobio, their second venture, they are pursuing first-in-class therapies against hard-to-drug oncogenic targets such as SHP2, for which no commercialized drugs currently exist.

Summary

Jacobio Pharma is an Oncology company based in Beijing, China, founded in 2015. It has raised $55.0M in total across 3 rounds, most recently a $55.0M Series C round in Aug 2018. Investors include Lilly Asia Ventures, Qiming VP and Hillhouse Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPO2020 (est.)

Sign up to see all 4 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Atomwise

AI-native drug discovery company, now operating as Numerion Labs, that uses machine learning to e...

San Francisco, United States51–200Biotech, Artificial Intelligence
Series CTotal funding$213.0MMar 2024
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Jacobio Pharma on Indexed.vc
<a href="https://indexed.vc/companies/jacobio-pharma"><img src="https://indexed.vc/api/badge/company/jacobio-pharma" alt="Jacobio Pharma on Indexed.vc" width="260" height="76" /></a>